You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

CMML

Showing 51 - 75 of 200
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Higher Risk Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia Trial (AMG 176, Azacitidine)

Not yet recruiting
  • Higher Risk Myelodysplastic Syndrome
  • Chronic Myelomonocytic Leukemia
  • (no location specified)
Jul 29, 2022

MDS/MPN Trial in Nanjing (Azacitidine (AZA) with Ruxolitinib)

Recruiting
  • MDS/MPN
  • Azacitidine (AZA) with Ruxolitinib
  • Nanjing, Jiangsu, China
    The First Affiliated Hospital of Nanjing Medical University
Apr 17, 2023

MDS, Chronic Myelomonocytic Leukemia, Acute Myeloid Leukemia Trial in Sydney (Decitabine/Cedazuridine 35 Mg-100 Mg ORAL TABLET,

Recruiting
  • Myelodysplastic Syndromes
  • +2 more
  • Decitabine/Cedazuridine 35 Mg-100 Mg ORAL TABLET
  • Defactinib
  • Sydney, New South Wales, Australia
  • +3 more
Jan 12, 2023

Disease-free Survival Trial in Shanghai (MBF-RIC)

Recruiting
  • Disease-free Survival
  • Shanghai, Shanghai, China
  • +1 more
Jun 28, 2022

Chronic Myelomonocytic Leukemia Trial in Houston (Azacitidine, Tamibarotene, Venetoclax)

Not yet recruiting
  • Chronic Myelomonocytic Leukemia
  • Houston, Texas
    M D Anderson Cancer Center
Oct 10, 2023

Acute Myeloid Leukemia, Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Newcastle (Bisantrene DiHCl

Recruiting
  • Acute Myeloid Leukemia
  • +4 more
  • Bisantrene Dihydrochloride (high dose)
  • +3 more
  • Newcastle, New South Wales, Australia
    Calvary Mater
Jul 14, 2022

Ascorbic Acid Levels in MDS, AML, and CMML Patients

Completed
  • Myelodysplastic Syndromes
  • +5 more
  • Peripheral blood collection
  • Grand Rapids, Michigan
  • +1 more
Sep 30, 2019

Acute Myeloid Leukemia, Acute Myeloid Leukemia With Multilineage Dysplasia, Chronic Myelomonocytic Leukemia Trial in Chapel

Recruiting
  • Acute Myeloid Leukemia
  • +5 more
  • Biospecimen Collection
  • +3 more
  • Baltimore, Maryland
  • +2 more
Jan 19, 2023

Acute Myeloid Leukemia, MDS, Chronic Myelomonocytic Leukemia Trial in United States (E7820)

Recruiting
  • Acute Myeloid Leukemia
  • +2 more
  • Miami, Florida
  • +6 more
Apr 25, 2022

Acute Myeloid Leukemia, MDS, Chronic Myelomonocytic Leukemia Trial in Rochester (Hyperbaric oxygen)

Recruiting
  • Acute Myeloid Leukemia
  • +6 more
  • Hyperbaric oxygen
  • Rochester, New York
    Wilmot Cancer Institute, University of Rochester
May 16, 2022

Myelodysplastic Syndrome, Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial (UAE Inhibitor TAK-243)

Not yet recruiting
  • Myelodysplastic Syndrome
  • +4 more
  • UAE Inhibitor TAK-243
  • (no location specified)
Oct 20, 2022

A Prospective, Multicentre European Registry for Newly Diagnosed

Recruiting
  • Myelodysplastic Syndromes (MDS)
  • No interventions
  • Innsbruck, Austria
  • +17 more
Dec 28, 2020

Myelodysplastic Syndrome, Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia Trial in Boston (biological, procedure, drug)

Terminated
Has Results
  • Myelodysplastic Syndrome
  • +2 more
  • GVAX
  • +6 more
  • Boston, Massachusetts
  • +3 more
Jun 30, 2022

MDS, Chronic Myelomonocytic Leukemia, Acute Myeloid Leukemia Trial in Worldwide (Panobinostat (LBH589), 5-Azacytidine)

Completed
Has Results
  • Myelodysplastic Syndromes
  • +2 more
  • Augusta, Georgia
  • +37 more
Jul 20, 2020

Leukemia, Myelomonocytic, Chronic Trial in United States (Tipifarnib)

Completed
  • Leukemia, Myelomonocytic, Chronic
  • Scottsdale, Arizona
  • +7 more
May 12, 2021

Clonal Cytopenia of Undetermined Significance Trial in Columbus (procedure, drug, other)

Recruiting
  • Clonal Cytopenia of Undetermined Significance
  • Biospecimen Collection
  • +6 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Dec 12, 2022

Multiple Myeloma, Acute Myeloid Leukemia, Non Hodgkin Lymphoma Trial in United States (PRT1419)

Completed
  • Multiple Myeloma
  • +3 more
  • Denver, Colorado
  • +4 more
Nov 14, 2022

Acute Myeloid Leukemia, MDS, Lymphoma Trial in United States (azacitidine)

Completed
  • Acute Myeloid Leukemia
  • +4 more
  • Greenbrae, California
  • +10 more
Nov 6, 2019

Chronic Myelomonocytic Leukemia, Myelodysplastic Syndrome, Recurrent Chronic Myelomonocytic Leukemia Trial in Houston

Recruiting
  • Chronic Myelomonocytic Leukemia
  • +5 more
  • Canakinumab
  • Houston, Texas
    M D Anderson Cancer Center
Dec 7, 2022

Leukemia Trial in France, United States (BAY2402234)

Terminated
  • Leukemia
  • Bronx, New York
  • +4 more
Dec 20, 2021

Chronic Myelomonocytic Leukemia, Myelodysplastic Syndrome, Myelodysplastic Syndrome With Excess Blasts Trial (Biospecimen

Not yet recruiting
  • Chronic Myelomonocytic Leukemia
  • +3 more
  • Biospecimen Collection
  • +3 more
  • (no location specified)
Oct 27, 2022

Acute Myeloid Leukemia, MDS, Chronic Myelomonocytic Leukemia Trial in Worldwide (JNJ-74856665, AZA, VEN)

Active, not recruiting
  • Acute Myeloid Leukemia
  • +2 more
  • Birmingham, Alabama
  • +22 more
Jan 27, 2023

MDS (MDS), Chronic Myelomonocytic Leukemia (CMML), Acute Myelogenous Leukemia (AML) Trial in United States (Subcutaneous (SC)

Completed
  • Myelodysplastic Syndromes (MDS)
  • +2 more
  • Subcutaneous (SC) Azacitidine
  • Oral Azacitidine
  • Gainesville, Florida
  • +17 more
Nov 6, 2019

Ruling Out Myelodysplastic Syndromes: Protocol forDiagnostic

Recruiting
  • Myelodysplastic Syndromes
  • Flow cytometric analysis of neutrophil myeloperoxidase expression
  • Clermont-Ferrand, France
  • +5 more
Mar 24, 2022

Leukemia, Myeloid, Acute, MDS, Leukemia, Myelomonocytic, Chronic Trial in Worldwide (H3B-8800 (RVT-2001))

Recruiting
  • Leukemia, Myeloid, Acute
  • +2 more
  • H3B-8800 (RVT-2001)
  • Stanford, California
  • +26 more
Mar 23, 2022